Imatinib Mesylate vs Tofacitinib
Imatinib Mesylate vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Imatinib Mesylate and Tofacitinib.
Mechanism of Action
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Tofacitinib — 3.2 hours.
Chemical Properties
Molecular Formula: Tofacitinib — C16H20N6O.
Molecular Weight: Tofacitinib — 312.3700 g/mol.
Type: Imatinib Mesylate — Small molecule; Tofacitinib — Small molecule.